Physician profile
Sally Crisp
NPI 1316603640
$1,655.97
in general payments reported to CMS, 2019-2025
18 companies · $40.36 in 2025
The $40.36 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,616 · 2025: $40.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $332.34 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $300.47 | 2022 | |
| Vanda Pharmaceuticals INC. | $152.67 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.45 | 2022 | |
| Alkermes, INC. | $111.11 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $106.61 | 2022 | |
| Neurocrine Biosciences, INC. | $96.04 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $93.89 | 2022 | |
| Janssen Pharmaceuticals, INC | $83.01 | 2022 | |
| Noven Therapeutics, LLC | $82.48 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.36 | 2025 | Cobenfy |
| Almatica Pharma LLC | $28.97 | 2022 | |
| Noven Pharmaceuticals, INC. | $24.02 | 2022 | |
| Ucb, INC. | $22.86 | 2022 | |
| Abbvie INC. | $20.37 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $14.37 | 2022 | |
| Indivior INC. | $14.17 | 2022 | |
| Merck Sharp & Dohme LLC | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Crisp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.